Evidence map›Paper›PMID 35422420›Full record

ArticleAJNR. American journal of neuroradiology2022

Iodine Maps from Dual-Energy CT to Predict Extrathyroidal Extension and Recurrence in Papillary Thyroid Cancer Based on a Radiomics Approach.

X-Q Xu, Y Zhou, G-Y Su, X-W Tao, Y-Q Ge, Y Si, M-P Shen, F-Y Wu

Open access · bronzeAbstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Radiomics in thyroid nodule assessment.BMC medical imaging · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Dual-Energy CT in Oncologic Imaging.Tomography (Ann Arbor, Mich.) · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

X-Q XuFrom the Departments of Radiology (X.-Q.X., Y.Z., G.-Y.S., F.-Y.W.).ORCID 0000-0001-5493-5256
Y ZhouFrom the Departments of Radiology (X.-Q.X., Y.Z., G.-Y.S., F.-Y.W.).ORCID 0000-0001-7895-6406
G-Y SuFrom the Departments of Radiology (X.-Q.X., Y.Z., G.-Y.S., F.-Y.W.).ORCID 0000-0002-2017-4329
X-W TaoSiemens Healthineers (X.-W.T., Y.-Q.G.), Shanghai, China.ORCID 0000-0003-1201-6037
Y-Q GeSiemens Healthineers (X.-W.T., Y.-Q.G.), Shanghai, China.ORCID 0000-0001-8589-6624
Y SiThyroid Surgery (Y.S., M.-P.S.), The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID 0000-0002-8601-2226
M-P ShenThyroid Surgery (Y.S., M.-P.S.), The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID 0000-0002-6560-330X
F-Y WuFrom the Departments of Radiology (X.-Q.X., Y.Z., G.-Y.S., F.-Y.W.) wfy_njmu@163.com.ORCID 0000-0002-0343-0458
World Wide Web Consortium · USJiangsu Province Hospital · CNSiemens Healthcare (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeAccurate prediction of extrathyroidal extension and subsequent recurrence is crucial in papillary thyroid cancer clinical management. Our aim was to conduct iodine map-based radiomics to predict extrathyroidal extension and to explore its prognostic value for recurrence-free survival in papillary thyroid cancer. MATERIALS AND

methodsA total of 452 patients with papillary thyroid cancer were retrospectively recruited between June 2017 and June 2020. Radiomics features were extracted from noncontrast images, dual-phase mixed images, and iodine maps, respectively. Random forest and least absolute shrinkage and selection operator (LASSO) were applied to build 6 radiomics scores (noncontrast radiomics score_random forest; noncontrast rad-score_LASSO; mixed rad-score_random forest; mixed rad-score_LASSO; iodine radiomics score_random forest; iodine radiomics score_LASSO) respectively. Logistic regression was used to construct 6 radiomics models incorporating 6 radiomics scores with clinical risk factors and to compare them with the clinical model. A radiomics model that achieved the highest performance was presented as a nomogram and assessed by discrimination, calibration, clinical usefulness, and prognosis evaluation.

resultsIodine radiomics scores performed significantly better than mixed radiomics scores. Both of them outperformed noncontrast radiomics scores. Iodine map-based radiomics models significantly surpassed the clinical model. A radiomics nomogram incorporating size, capsule contact, and iodine radiomics score_random forest was built with the highest performance (training set, area under the curve = 0.78; validation set, area under the curve  = 0.84). Stratified analysis confirmed the nomogram stability, especially in group negative for CT-reported extrathyroidal extension (area under the curve  = 0.69). Nomogram-predicted extrathyroidal extension risk was an independent predictor of recurrence-free survival. A high risk for extrathyroidal extension portended significantly lower recurrence-free survival than low risk (

conclusionsIodine map-based radiomics might be a supporting tool for predicting extrathyroidal extension and subsequent recurrence risk in patients with papillary thyroid cancer, thus facilitating clinical decision-making.

Indexed as

IodineThyroid NeoplasmsHumansNomogramsRetrospective StudiesThyroid Cancer, PapillaryTomography, X-Ray ComputedIodine

Identifiers

PMID35422420
PMCPMC9089265
OpenAlexW4223905945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.